Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
NLRP3 Inflammasome and MS/EAE.
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Few patients with neurodegenerative disorders require spinal surgery.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Direct effects of secretory products of immune cells on neurons and glia.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Glial progenitor cell-based treatment and modeling of neurological disease.
No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
Self-intermittent catheterization in multiple sclerosis.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
Multiple sclerosis patients and clinical care in Taiwan.
Pages
« first
‹ previous
…
312
313
314
315
316
317
318
319
320
…
next ›
last »